Replies to post #62027 on NanoViricides Inc. (NNVC)

[leifsmith]

Patrick Cox, on NanoViricides, in Breakthrough Technology Alert, 14 Aug 2012

Summary:

Astonishing news about NNVC ... oral delivery efficacy ... "really stunning."
polymer nanotech structures, ligands, viruses attachment, destruction.
virus population rapidly reduced, but immunity may still develop naturally.
"biggest breakthrough in virus-borne disease since Edward Jenner developed smallpox inoculation."
third party contract research organization shows oral effectiveness.
advantages to oral drugs: taken outside clinical setting delivered quickly, easily.
same technology will probably work for other viricides.
toxicity of polymer ligand constructs low .... still must be proved.
viricides inexpensive to produce at commercial scale.
high profit margins, because
Medicare pays hospitals by disease not by length of stay.
accelerate recovery, hospitals make money.
250,000 hospitalized for flu a year in USA.
Tamiflu not very effective.
pandemic danger always with us, seals, birds, etc.
quotes from Diwan, Barton, Seymour, taken from press release.